RespirAI Medical

Company Overview

Snapshot

Founded in October 2020 by Nimrod Bin-Nun and Assaf Gur, RespirAI Medical operates with 1–10 employees. The company has raised $1M across five funding rounds. In January 2025, RespirAI Medical secured a grant from the BIRD Foundation.

Business overview

RespirAI Medical develops a wearable disease-management platform for home monitoring, enabling patients to manage multiple health conditions. The system utilizes easy-to-wear passive sensing technology to capture medical-grade physiological data, which is then synced to the cloud for analysis using advanced algorithms and artificial intelligence. This technology allows for early detection of changes in patient health, improving quality of life and reducing healthcare costs. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Patient Remote Monitoring, serving patients and healthcare providers.

Strategic signal

In August 2024, news emerged about RespirAI Medical's technology potentially predicting COPD flare-ups via smartwatches. This indicates a significant advancement in leveraging wearable technology for proactive disease management, suggesting a strong potential for improving patient outcomes and reducing acute care interventions in chronic respiratory conditions. This development validates the company's AI-driven approach to early detection and remote monitoring, positioning it as an innovator in the digital health space.

Company Intelligence Q&A

What is RespirAI Medical's core technology?

RespirAI Medical's core technology is a wearable passive sensing system that captures medical-grade physiological data. This data is then analyzed using advanced algorithms and artificial intelligence to detect early changes in patient health for home-based disease management.

When was RespirAI Medical founded?

RespirAI Medical was founded in October 2020 by Nimrod Bin-Nun and Assaf Gur.

Which investor participated in RespirAI Medical's funding rounds?

eHealth Ventures participated as an investor in RespirAI Medical's funding rounds, including a Pre-Seed round in January 2022 and a Seed round in January 2021.

Has RespirAI Medical received any grants?

Yes, RespirAI Medical secured a grant from the BIRD Foundation in January 2025. The company also received a grant in April 2024 and another in January 2021.

What is the strategic focus of RespirAI Medical's platform?

RespirAI Medical's platform focuses on home-based disease management, aiming to improve patients' quality of life and reduce healthcare system costs by enabling early detection of health changes before symptoms become apparent.